RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment.
Andrea Emanuele GueriniAlessandra TucciFilippo AlongiEneida MatajAngelo BelottiPaolo BorghettiLuca TriggianiLudovica PegurriSara PedrettiMarco BonùDavide TomasiniJessica ImbresciaAlessandra DonofrioGiorgio FacherisNavdeep SinghGiulia VolpiCesare TomasiStefano Maria MagriniLuigi SpiazziMichela BuglionePublished in: Cancers (2022)
Radiotherapy resulted in optimal pain control rates and fair toxicity, regardless of BED 10 and CST; the treatments with higher BED 10 and CST (remarkably biological agents) improved the already excellent radiological disease control.